Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect

In oncology, the “abscopal effect” refers to the therapeutic effect on a distant tumor resulting from the treatment of local tumor (e. g., ablation, injection, or radiation). Typically associated with radiation, the abscopal effect is thought to be mediated by a systemic antitumor immune response th...

Full description

Bibliographic Details
Main Authors: Nathan Suek, Luis Felipe Campesato, Taha Merghoub, Danny N. Khalil
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00604/full
_version_ 1828403222185771008
author Nathan Suek
Luis Felipe Campesato
Taha Merghoub
Taha Merghoub
Danny N. Khalil
Danny N. Khalil
author_facet Nathan Suek
Luis Felipe Campesato
Taha Merghoub
Taha Merghoub
Danny N. Khalil
Danny N. Khalil
author_sort Nathan Suek
collection DOAJ
description In oncology, the “abscopal effect” refers to the therapeutic effect on a distant tumor resulting from the treatment of local tumor (e. g., ablation, injection, or radiation). Typically associated with radiation, the abscopal effect is thought to be mediated by a systemic antitumor immune response that is induced by two concurrent changes at the treated tumor: (1) the release of tumor antigens and (2) the exposure of damage-associated molecular patterns. Therapies that produce these changes are associated with immunogenic cell death (ICD). Some interventions have been shown to cause an abscopal effect without inducing the release of tumor antigens, suggesting that release of tumor antigens at baseline plays a significant role in mediating the abscopal effect. With tumor antigens already present, therapies that target activation of APCs alone may be sufficient to enhance the abscopal effect. Here, we discuss two therapies targeted at APC activation, TLR9 and CD40 agonists, and their use in the clinic to enhance the abscopal effect.
first_indexed 2024-12-10T10:14:25Z
format Article
id doaj.art-eb8d504f838246209608f0e390713616
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-10T10:14:25Z
publishDate 2019-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-eb8d504f838246209608f0e3907136162022-12-22T01:53:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-04-011010.3389/fimmu.2019.00604430078Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal EffectNathan Suek0Luis Felipe Campesato1Taha Merghoub2Taha Merghoub3Danny N. Khalil4Danny N. Khalil5Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesSwim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesSwim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesDepartment of Medicine, Weill Cornell Medical College, New York, NY, United StatesSwim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesDepartment of Medicine, Weill Cornell Medical College, New York, NY, United StatesIn oncology, the “abscopal effect” refers to the therapeutic effect on a distant tumor resulting from the treatment of local tumor (e. g., ablation, injection, or radiation). Typically associated with radiation, the abscopal effect is thought to be mediated by a systemic antitumor immune response that is induced by two concurrent changes at the treated tumor: (1) the release of tumor antigens and (2) the exposure of damage-associated molecular patterns. Therapies that produce these changes are associated with immunogenic cell death (ICD). Some interventions have been shown to cause an abscopal effect without inducing the release of tumor antigens, suggesting that release of tumor antigens at baseline plays a significant role in mediating the abscopal effect. With tumor antigens already present, therapies that target activation of APCs alone may be sufficient to enhance the abscopal effect. Here, we discuss two therapies targeted at APC activation, TLR9 and CD40 agonists, and their use in the clinic to enhance the abscopal effect.https://www.frontiersin.org/article/10.3389/fimmu.2019.00604/fullabscopal effectAPC activationDCimmunogenic cell death (ICD)CD40LTLR9
spellingShingle Nathan Suek
Luis Felipe Campesato
Taha Merghoub
Taha Merghoub
Danny N. Khalil
Danny N. Khalil
Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
Frontiers in Immunology
abscopal effect
APC activation
DC
immunogenic cell death (ICD)
CD40L
TLR9
title Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
title_full Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
title_fullStr Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
title_full_unstemmed Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
title_short Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
title_sort targeted apc activation in cancer immunotherapy to enhance the abscopal effect
topic abscopal effect
APC activation
DC
immunogenic cell death (ICD)
CD40L
TLR9
url https://www.frontiersin.org/article/10.3389/fimmu.2019.00604/full
work_keys_str_mv AT nathansuek targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect
AT luisfelipecampesato targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect
AT tahamerghoub targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect
AT tahamerghoub targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect
AT dannynkhalil targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect
AT dannynkhalil targetedapcactivationincancerimmunotherapytoenhancetheabscopaleffect